SE524337C2 - Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär - Google Patents

Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär

Info

Publication number
SE524337C2
SE524337C2 SE9803541A SE9803541A SE524337C2 SE 524337 C2 SE524337 C2 SE 524337C2 SE 9803541 A SE9803541 A SE 9803541A SE 9803541 A SE9803541 A SE 9803541A SE 524337 C2 SE524337 C2 SE 524337C2
Authority
SE
Sweden
Prior art keywords
medicament
xanthophyll
astaxanthin
prophylactic
use according
Prior art date
Application number
SE9803541A
Other languages
English (en)
Swedish (sv)
Other versions
SE9803541D0 (sv
SE9803541L (sv
Inventor
Aake Lignell
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9803541A priority Critical patent/SE524337C2/sv
Publication of SE9803541D0 publication Critical patent/SE9803541D0/xx
Priority to AU62016/99A priority patent/AU763995B2/en
Priority to DE69918152T priority patent/DE69918152T2/de
Priority to PCT/EP1999/007551 priority patent/WO2000023064A1/en
Priority to ES99948969T priority patent/ES2222732T3/es
Priority to EP99948969A priority patent/EP1121106B1/en
Priority to AT99948969T priority patent/ATE269065T1/de
Priority to US09/463,958 priority patent/US6923967B1/en
Priority to CA002346647A priority patent/CA2346647C/en
Priority to JP2000576839A priority patent/JP2002527472A/ja
Publication of SE9803541L publication Critical patent/SE9803541L/
Priority to NO20011667A priority patent/NO330158B1/no
Publication of SE524337C2 publication Critical patent/SE524337C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9803541A 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär SE524337C2 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
JP2000576839A JP2002527472A (ja) 1998-10-16 1999-10-08 消化不良の処置
ES99948969T ES2222732T3 (es) 1998-10-16 1999-10-08 Tratamiento de la indigestion.
DE69918152T DE69918152T2 (de) 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen
PCT/EP1999/007551 WO2000023064A1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
AU62016/99A AU763995B2 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
EP99948969A EP1121106B1 (en) 1998-10-16 1999-10-08 Treatment of indigestion
AT99948969T ATE269065T1 (de) 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen
US09/463,958 US6923967B1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
CA002346647A CA2346647C (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
NO20011667A NO330158B1 (no) 1998-10-16 2001-04-03 Anvendelse av xantofyller

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär

Publications (3)

Publication Number Publication Date
SE9803541D0 SE9803541D0 (sv) 1998-10-16
SE9803541L SE9803541L (sv) 2000-04-17
SE524337C2 true SE524337C2 (sv) 2004-07-27

Family

ID=20412979

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär

Country Status (11)

Country Link
US (1) US6923967B1 (no)
EP (1) EP1121106B1 (no)
JP (1) JP2002527472A (no)
AT (1) ATE269065T1 (no)
AU (1) AU763995B2 (no)
CA (1) CA2346647C (no)
DE (1) DE69918152T2 (no)
ES (1) ES2222732T3 (no)
NO (1) NO330158B1 (no)
SE (1) SE524337C2 (no)
WO (1) WO2000023064A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4933097B2 (ja) * 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
JPWO2014208511A1 (ja) * 2013-06-27 2017-02-23 学校法人同志社 アスタキサンチン含有腸内フローラ改善組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57105145A (en) * 1980-12-23 1982-06-30 Koichi Tanaka Feed additive
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IL110139A0 (en) 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH10513444A (ja) * 1995-02-03 1998-12-22 ビーエーエスエフ アクチェンゲゼルシャフト 皮膚疾患の治療のための医薬品の製造のためのカロチノイドの使用
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE522246C2 (sv) * 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Also Published As

Publication number Publication date
ATE269065T1 (de) 2004-07-15
CA2346647A1 (en) 2000-04-27
WO2000023064A1 (en) 2000-04-27
ES2222732T3 (es) 2005-02-01
SE9803541D0 (sv) 1998-10-16
DE69918152T2 (de) 2005-07-07
CA2346647C (en) 2003-03-11
US6923967B1 (en) 2005-08-02
SE9803541L (sv) 2000-04-17
NO330158B1 (no) 2011-02-28
DE69918152D1 (de) 2004-07-22
NO20011667L (no) 2001-04-03
AU6201699A (en) 2000-05-08
AU763995B2 (en) 2003-08-07
EP1121106A1 (en) 2001-08-08
EP1121106B1 (en) 2004-06-16
NO20011667D0 (no) 2001-04-03
JP2002527472A (ja) 2002-08-27

Similar Documents

Publication Publication Date Title
US6265450B1 (en) Anti-stress composition
EP1011653B1 (en) Use of xanthophylles in medicaments for improvement of duration of muscle function or treatment of muscle disorders or diseases
EP0981338B1 (en) Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
KR101800632B1 (ko) 엔테로코커스 패칼리스, 이의 배양액 또는 이의 사균체를 유효성분으로 함유하는 근육감퇴, 약화 및 근위축 예방, 개선 또는 치료용 약학 조성물, 식품 조성물 및 식품첨가제
US20050267212A1 (en) Omega-3 fatty acids in the treatment of depression
SE511237C2 (sv) Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
US20220062225A1 (en) Methods for reducing negative effects of alcohol consumption
WO2020154712A1 (en) Compositions and methods for improving quality of life in patients with autism spectrum disorder
US20090281065A1 (en) Use of Lysophospholipids to Treat Inflammation
SE524337C2 (sv) Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
WO2010002406A1 (en) Compositions comprising rhodiola rosea and methods of use thereof
JP2009269832A (ja) カルシトニン遺伝子関連ペプチド及びインスリン様成長因子−１の産生促進組成物
CN101288675A (zh) 一种治疗心脑血管类疾病的药物及其生产方法
US10328090B2 (en) Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
KR101472609B1 (ko) 제니스테인의 신규 용도
US20100003351A1 (en) Compositions comprising rhodiola rosea and methods of use thereof
US20070298136A1 (en) Cholesterol regulating agent
JP2011207815A (ja) 抗酸化ストレス剤
JP2016065056A (ja) 組成物、その使用、および製造方法
US20040006048A1 (en) Combination of lecithin with ascorbic acid
CN111467385B (zh) 组合物在预防或治疗神经退行性疾病中的用途
US20040131644A1 (en) Composition and method for treating age-related disorders
WO2022075375A1 (ja) トランスサイレチン四量体安定化剤、及び、トランスサイレチンアミロイドーシス予防剤又は進行抑制剤
KR20220123272A (ko) 인지 장애 치료용 조성물
JP2024158237A (ja) エフェロサイトーシス促進剤

Legal Events

Date Code Title Description
NUG Patent has lapsed
NUG Patent has lapsed